Frontiers in Pharmacology | Neuropharmacology

Systematic Review

Published on 16 Dec 2022

Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis

in Neuropharmacology

Lanlan Zhang
Yuehong Li
Weikai Wang
Chengzhong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.978876

3,904 views
3 citations

Original Research

Published on 16 Dec 2022

Hyperglycemia-associated Alzheimer’s-like symptoms and other behavioral effects attenuated by Plumeria obtusa L. Extract in alloxan-induced diabetic rats

in Neuropharmacology

Sumeera Naz
Imran Imran
Muhammad Asad Farooq
Syed Adil Hussain Shah
Iqra Ajmal
Zartash Zahra
Aqsa Aslam
Muhammad Irfan Sarwar
Jaffer Shah
Ambreen Aleem

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1077570

5,509 views
2 citations

Original Research

Published on 16 Dec 2022

Role of 5-HT1A-mediated upregulation of brain indoleamine 2,3 dioxygenase 1 in the reduced antidepressant and antihyperalgesic effects of fluoxetine during maintenance treatment

in Neuropharmacology

Jiajia Dai
Hyangin Kim
Zerong You
Michael F. McCabe
Shuzhuo Zhang
Shiyu Wang
Grewo Lim
Lucy Chen
Jianren Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1084108

2,953 views
2 citations

Original Research

Published on 15 Dec 2022

Endocannabinoid metabolism inhibition has no effect on spontaneous fear recovery or extinction resistance in Lister hooded rats

in Neuropharmacology

William G. Warren
Eleni P. Papagianni
Ed Hale
Rebecca A. Brociek
Helen J. Cassaday
Carl W. Stevenson

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1082760

1,822 views

Original Research

Published on 15 Dec 2022

TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway

in Neuropharmacology

Zeyang Li
Minghui Zhao
Xiaoqian Zhang
Yiran Lu
Yang Yang
Yalong Xie
Zhimiao Zou
Liang Zhou
Runshi Shang
Limin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1080438

4,196 views
6 citations

Mini Review

Published on 14 Dec 2022

APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer’s disease

in Neuropharmacology

Rebeca Lapresa
Jesus Agulla
Juan P. Bolaños
Angeles Almeida

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1086540

4,752 views
8 citations

Original Research

Published on 14 Dec 2022

Heightened cocaine-seeking in male rats associates with a distinct transcriptomic profile in the medial prefrontal cortex

in Neuropharmacology

Christina R. Merritt
Ashley E. Smith
Kamil Khanipov
George Golovko
Kelly T. Dineley
Noelle C. Anastasio
Kathryn A. Cunningham

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1022863

2,996 views
4 citations

Original Research

Published on 13 Dec 2022

The mechanisms underlying the actions of Xuefu Zhuyu decoction pretreatment against neurological deficits after ischemic stroke in mice: The mediation of glymphatic function by aquaporin-4 and its anchoring proteins

in Neuropharmacology

Ting Yi
Ping Gao
Meng Hou
Huan Lv
Mengyuan Huang
Shanshan Gao
Jinrong He
Dongdong Yang
Weiyin Chen
Tianmin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053253

4,224 views
13 citations

Original Research

Published on 08 Dec 2022

Gastrodin ameliorates the lipopolysaccharide-induced neuroinflammation in mice by downregulating miR-107-3p

in Neuropharmacology

Jin-Jin Song
Hui Li
Nan Wang
Xiao-Yan Zhou
Yan Liu
Zhen Zhang
Qian Feng
Yu-Ling Chen
Dan Liu
Jia Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1044375

4,502 views
16 citations

Original Research

Published on 06 Dec 2022

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor

in Neuropharmacology

Shouyuan Sun
Tao Shi
Yan Peng
Honghua Zhang
Linsheng Zhuo
Xue Peng
Qien Li
Manxia Wang
Shuzhi Wang
Zhen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1043397

2,511 views
3 citations

Mini Review

Published on 06 Dec 2022

Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology

in Neuropharmacology

Octavian Buda
Sorin Hostiuc
Ovidiu Popa-Velea
Steluta Boroghina

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053534

2,625 views
1 citation

Original Research

Published on 06 Dec 2022

The efficacy and safety of epidural morphine/hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study

in Neuropharmacology

Sun Yiping
Shen Jiayi
Hei Guang
Ji Yun
Ma Bingjie
Huang Xuehua
Yu Zhiyuan
Ma Pingchuan
Ma Ke

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1051357

2,576 views
4 citations

Editorial

Published on 01 Dec 2022

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II

in Neuropharmacology

Kyriaki Thermos
Stephanie C. Joachim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1104105

928 views

Editorial

Published on 30 Nov 2022

Editorial: The pharmacotherapy of depression—searching for new mechanisms and drug interactions basic and clinical research

in Neuropharmacology

Katarzyna Stachowicz
Magdalena Sowa-Kućma
Anna Tabecka-Łonczyńska

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1098660

1,199 views

Mini Review

Published on 30 Nov 2022

Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration

in Neuropharmacology

Andrew K. Evans
Erwin Defensor
Mehrdad Shamloo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1030609

5,604 views
13 citations

Review

Published on 29 Nov 2022

Noble gas and neuroprotection: From bench to bedside

in Neuropharmacology

Haiying Yin
Zijun Chen
Hailin Zhao
Han Huang
Wenwen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028688

6,108 views
20 citations